(Q47865052)

6 February 2018

title

Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model (English)

1 reference

6 February 2018

0 references

0 references

Brioni R Moore

3

0 references

Kevin Batty

object named as

Kevin T Batty

2

0 references

Carl Kirkpatrick

object named as

Carl M Kirkpatrick

5

0 references

author name string

Kashyap Patel

1

1 reference

6 February 2018

Peter L Gibbons

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

28 April 2014

1 reference

6 February 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

6 February 2018

volume

69

1 reference

6 February 2018

issue

8

1 reference

6 February 2018

page(s)

2155-2163

1 reference

6 February 2018

Clinical pharmacology of artemisinin-based combination therapies

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Antimalarial dosing regimens and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Towards optimal design of anti-malarial pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

A research agenda for malaria eradication: drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Mathematical modelling of the within-host dynamics of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Intrahost modeling of artemisinin resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Ways to fit a PK model with some data below the quantification limit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Toxicology and pharmacokinetics of piperaquine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Altered temporal response of malaria parasites determines differential sensitivity to artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: flavin reductase and the cofactor model exemplified

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

The molecular mechanism of action of artemisinin--the debate continues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Qinghaosu (Artemisinin): The Price of Success

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Piperaquine: a resurgent antimalarial drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

Comparative morphology of human and animal malaria parasites. I. Host-parasite interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

The relevance of non-human primate and rodent malaria models for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU120

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU120

1 reference

6 February 2018

1 reference

6 February 2018